A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
Beijing Biotech
National Institutes of Health Clinical Center (CC)
Blokhin's Russian Cancer Research Center
Neonc Technologies, Inc.
Essen Biotech
University of Nebraska
Adela, Inc
Var2 Pharmaceuticals
Mayo Clinic
Cancer Research UK
Massive Bio, Inc.
LigaChem Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Apollomics Inc.
Columbia University
Stanford University
Hospices Civils de Lyon